Literature DB >> 11150536

ELISPOT assay for detection of peptide specific interferon-gamma secreting cells in rhesus macaques.

A Kumar1, W Weiss, J A Tine, S L Hoffman, W O Rogers.   

Abstract

A reliable procedure to measure antigen specific T cell responses in rhesus macaques is required to determine the efficacy of vaccines and immunotherapies. The currently available T cell assays are poorly quantifiable or technically difficult to perform. Classical 51Cr-release cytotoxic T cell (CTL) assays are cumbersome and difficult to quantitate reproducibly. Detection of specific T-cell using MHC-peptide tetrameric complexes is highly sensitive, but requires knowledge of MHC type and prior identification of T cell epitopes. We therefore developed a rhesus interferon-gamma (IFN-gamma) ELISPOT assay capable of detecting IFN-gamma secretion in response to stimulation with pooled 20-mer peptides. Peripheral blood mononuclear cells (PBMCs) from rhesus monkeys immunized with a DNA vaccine and recombinant canary pox encoding the Plasmodium knowlesi circumsporozoite protein (PkCSP) were incubated with pools of peptides from PkCSP. Positive responses to peptide pools and individual peptides ranging from 100 to 450 spot forming cells (SFC)/10(6) PBMC were detected in four of four immunized monkeys and in zero of two control monkeys. In two monkeys studied in detail, the IFN-gamma response was focussed on a single 20-mer peptide, QGDGANAGQPQAQGDGANAG, and was dependent on CD4(+), but not CD8(+), T cells. Background responses in control monkeys and preimmunization PBMCs ranged from 10 to 50 SFC/10(6) PBMC. The average within assay and between assay coefficients of variation (CV) for this peptide ELISPOT were 21.9 and 24.7%, respectively. This peptide IFN-gamma assay will be a useful tool for evaluation of T cell responses in rhesus macaques.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11150536     DOI: 10.1016/s0022-1759(00)00310-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  18 in total

1.  Analyzing cellular immunity to AAV in a canine model using ELISPOT assay.

Authors:  Zejing Wang; Rainer Storb; Stephen J Tapscott; Stanley Riddell
Journal:  Methods Mol Biol       Date:  2012

2.  A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses.

Authors:  Salix Boulet; Michel L Ndongala; Yoav Peretz; Marie-Pierre Boisvert; Mohamed-Rachid Boulassel; Cecile Tremblay; Jean-Pierre Routy; Rafick-P Sekaly; Nicole F Bernard
Journal:  J Immunol Methods       Date:  2006-12-29       Impact factor: 2.303

3.  Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease.

Authors:  Baoxi Qu; Roger N Rosenberg; Liping Li; Philip J Boyer; Stephen A Johnston
Journal:  Arch Neurol       Date:  2004-12

4.  Scrub typhus vaccine candidate Kp r56 induces humoral and cellular immune responses in cynomolgus monkeys.

Authors:  Suchismita Chattopadhyay; Ju Jiang; Teik-Chye Chan; T Scott Manetz; Chien-Chung Chao; Wei-Mei Ching; Allen L Richards
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene.

Authors:  Danilo R Casimiro; Aimin Tang; Helen C Perry; Romnie S Long; Minchun Chen; Gwendolyn J Heidecker; Mary-Ellen Davies; Daniel C Freed; Natasha V Persaud; Sheri Dubey; Jeffrey G Smith; Diane Havlir; Douglas Richman; Michael A Chastain; Adam J Simon; Tong-Ming Fu; Emilio A Emini; John W Shiver
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.

Authors:  Gerald V Quinnan; Xiao-Fang Yu; Mark G Lewis; Peng Fei Zhang; Gerd Sutter; Peter Silvera; Ming Dong; Anil Choudhary; Phuong T N Sarkis; Peter Bouma; Zhiqiang Zhang; David C Montefiori; Thomas C Vancott; Christopher C Broder
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice.

Authors:  Bao-Xi Qu; Qun Xiang; Liping Li; Stephen Albert Johnston; Linda S Hynan; Roger N Rosenberg
Journal:  J Neurol Sci       Date:  2007-06-15       Impact factor: 3.181

8.  Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria.

Authors:  Chandy C John; Ann M Moormann; Peter O Sumba; Ayub V Ofulla; Daniel C Pregibon; James W Kazura
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  Sterile protection against Plasmodium knowlesi in rhesus monkeys from a malaria vaccine: comparison of heterologous prime boost strategies.

Authors:  George Jiang; Meng Shi; Solomon Conteh; Nancy Richie; Glenna Banania; Harini Geneshan; Anais Valencia; Priti Singh; Joao Aguiar; Keith Limbach; Kurt I Kamrud; Jonathan Rayner; Jonathan Smith; Joseph T Bruder; C Richter King; Takafumi Tsuboi; Satoru Takeo; Yaeta Endo; Denise L Doolan; Thomas L Richie; Walter R Weiss
Journal:  PLoS One       Date:  2009-08-10       Impact factor: 3.240

10.  Development and evaluation of a real-time reverse transcription-PCR assay for quantification of gamma interferon mRNA to diagnose tuberculosis in multiple animal species.

Authors:  Noel P Harrington; Om P Surujballi; W Ray Waters; John F Prescott
Journal:  Clin Vaccine Immunol       Date:  2007-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.